Welcome to the e-CCO Library Archive!
P. Lunney1, V. Kariyawasam2, K. Middleton1, R. Wang1, T. Huang3, C. Selinger2, J. Andrews4, R. Leong2, 1The University of Sydney, Sydney Medical School, Sydney, Australia, 2Concord Repatriation General Hospital, Gastroenterology and Liver Services, Sydney, Australia, 3University of New South Wales, Australia, 4Royal Adelaide Hospital, Adelaide, Australia
Anti-TNF-induced skin manifestations in IBD patients: role for increased drug exposure?
I. Cleynen*1, W. Van Moerkercke2, T. Billiet1, N. Vande Casteele3, M. Ferrante2, M. Noman2, G. Van Assche2, P. Rutgeerts2, S. Segaert4, A. Gils3, S. Vermeire2
1KU Leuven, Clinical and experimental medicine, Leuven, Belgium, 2UZ Leuven, Gastroenterology, Leuven, Belgium, 3KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Therapeutic and Diagnostic Antibodies, Leuven, Belgium, 4UZ Leuven, Department of Dermatology, Leuven, Belgium
Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000–2012
B.P.M. Verhaegh1,2, D.M.A.E. Jonkers1,2, A. Driessen3, M.P. Zeegers2,4,5, A.A.M. Masclee1,2, M.J. Pierik1, 1Maastricht University Medical Center+, Internal Medicine – Division Gastroenterology-Hepatology, Maastricht, Netherlands, 2Maastricht University Medical Center+, NUTRIM, School for Nutrition, Toxicology and Metabolism, Maastricht, Netherlands, 3Antwerp University Hospital, Pathology, Edegem, Belgium, 4Maastricht University Medical Center+, Complex Genetics, Cluster of Genetics and Cell Biology, Maastricht, Netherlands, 5University of Birmingham, Public Health, Epidemiology and Biostatistics, Birmingham, United Kingdom
M. Di Girolamo1, A. Scarcelli1, A. Bertani1, A. Sartini1, A. Merighi1, E. Villa1, 1Policlinico Modena, Italy
Post-marketing experience of vedolizumab for IBD: The University of Chicago experience
B. Christensen*, S.R. Goeppinger, R. Colman, D. Siddiqui, A. Yarur, A.A. Bochenek, A. Wichmann, A. Hirsch, J. Kinnucan, A. Sakuraba, R. Cohen, D.T. Rubin
University of Chicago Inflammatory Bowel Disease Center, Gastroenterology, Chicago, IL, United States
Impact of psychological factors in relapse of Crohn's disease
A. Lainé1, A. Laurent1, A. Mariage1, B. Flourié2, S. Nancey3, 1University of Franche Comte, Psychology, Besançon, France, 2Hôpital Lyon Sud, service Gastro Entérologie, Lyon, France, 3Hôpital Lyon Sud, service Gastro Enterologie, Lyon, France
A. Vollebregt1, L. Bel1, A. van der Meulen1, H. Fidder2, R. Ten Hove3, C. Vliet-Vlieland4,5, M. ter Kuile4, E. de Groot4, S. Both4, 1Leiden University Medical Center, Gastroenterology, Leiden, The Netherlands, 2University Medical Centre Utrecht, Gastroenterology, Utrecht, The Netherlands, 3Diaconessenhuis Leiden, Gastroenterology, Leiden, The Netherlands, 4Leiden University Medical Center, Outpatient Clinic for Psychosomatic Gynaecology and Sexology, Leiden, Netherlands, 5General Practitioner Practice 't Wantveld, Noordwijk, The Netherlands
Different profile of efficacy of thiopurines in Ulcerative Colitis and Crohn's Disease
A. Testa*1, A. Rispo1, M. Rea1, G.D. De Palma2, M. Diaferia1, D. Musto1, F. Sasso1, N. Caporaso1, F. Castiglione1
1AOU Policlinico Federico II of Naples, Gastroenterology, Naples, Italy, 2AOU Policlinico Federico II of Naples, Surgery and Advanced Technologies, Naples, Italy
Impact of diagnostic delay on clinical outcome of Crohn's disease (CD)
F. Furfaro1, R. Sciurti1, C. Bezzio1, A. Dell'Era2, S. Ardizzone1, R. de Franchis2, G. Maconi1, 1Luigi Sacco University Hospital, Gastroenterology and IBD Unit, Milan, Italy, 2Luigi Sacco University Hospital, Gastroenterology Department, Milano, Italy
L. Hicks1, D. Walker1, D. Eng2, B. Jiminez2, J. Kinross2, E. Holmes2, H. Williams1, T. Orchard1, 1Imperial College London, Gastroenterology, London, United Kingdom, 2Imperial College London, Surgery and Cancer, London, United Kingdom
Analysis of Patient Perception of Pain and Management Strategies in IBD
M. Boyle*1, S. Murphy2, J. Leyden2, P. MacMathuna2, G. Doherty1, G. Cullen1
1St Vincents University Hospital, Gastroenterology, Dublin, Ireland, 2Mater Misercordiae University Hospital, Gastroenterology, Dublin , Ireland
Impact of depression on medication adherence in inflammatory bowel disease
L. Trikos1, D. Bojic2, V. Gligorijevic2, S. Markovic2, N. Jojic2, 1University Clinical Centre “Zvezdara”, Center of psychiatry, Belgrade, Serbia, 2University Clinical Centre “Zvezdara”, Department of Gastroenterology and Hepatology, Belgrade, Serbia
C. Vaizey1, P.R. Gibson2, C.M. Black3, R.J. Nicholls4, A.R. Weston4, D.R. Gaya5, S. Sebastian6, I. Shaw7, S. Lewis8, S. Bloom9, J.N. Gordon10, A. Beale11, I. Arnott12, S. Cambell13, T. Fan3, 1St Mark's Hospital, Department of Surgery, London, United Kingdom, 2Monash University, Victoria, Australia, 3Merck & Co. Inc., Global Health Outcomes, Whitehouse Station, United States, 4OptumInsight, Sydney, Australia, 5Glasgow Royal Infirmary, Gastroenterology Unit, Glasgow, United Kingdom, 6Hull Royal Infirmary, Department of Gastroenterology, Hull, United Kingdom, 7Gloucester Royal Hospital, Department of Gastroenterology, Gloucester, United Kingdom, 8Derriford Hospital, Department of Gastroenterology, Plymouth, United Kingdom, 9University College London Hospital, Department of Gastroenterology, London, United Kingdom, 10Royal Hampshire Hospital, Department of Gastroenterology, Winchester, United Kingdom, 11Bristol Royal Infirmary, Bristol, United Kingdom, 12Western General Hospital, Edinburgh, United Kingdom, 13Manchester Royal Infirmary, Manchester, United Kingdom
Adalimumab dose escalation is effective for managing loss of response in Ulcerative Colitis
C. Taxonera*1, 2, E. Iglesias3, F. Muñoz4, M. Calvo5, M. Barreiro-de Acosta6, D. Busquets7, X. Calvet8, A. Rodríguez9, R. Pajares10, J.P. Gisbert11, 12, J.L. Pérez-Calle13, P. López-Serrano13, A. Ponferrada14, C. de la Coba15, F. Bermejo16, M. Chaparro11, 12, J.L. Mendoza1, 2, D. Olivares1, 2, I. Fernández-Blanco17
1Hospital Clínico San Carlos, IBD Unit, Madrid, Spain, 2Hospital Clínico San Carlos, IdISSC, Madrid, Spain, 3Hospital Reina Sofía, Gastroenterology, Córdoba, Spain, 4Hospital de León, Gastroenterology, León, Spain, 5Hospital Puerta de Hierro, Gastroenterology Unit, Madrid, Spain, 6Hospital Clínico de Santiago, Gastroenterology, Santiago de Compostela, Spain, 7Hospital Josep Trueta, Gastroenterology, Girona, Spain, 8Corporació Sanitària Parc Taulí, Servei d'Aparell Digestiu, Sabadell, Spain, 9Hospital Universitario de Salamanca, Gastroenterology, Salamanca, Spain, 10Hospital Infanta Sofía, Gastroenterology, San Sebastián de los Reyes. Madrid, Spain, 11Hospital La Princesa, Gastroenterology Unit, Madrid, Spain, 12Hospital La Princesa , IP and CIBERehd, Gastroenterology, Madrid, Spain, 13Hospital de Alcorcón, Gastroenterology Unit, Madrid, Spain, 14Hospital Infanta Leonor, Gastroenterology, Madrid, Spain, 15Hospital de Cabueñes, Digestive Department, Gijon, Spain, 16Hospital de Fuenlabrada, Gastroenterology Unit, Madrid, Spain, 17Hospital Moncloa, Gastrointestinal Surgery, Madrid, Spain
Influence of coping strategies on the clinical course of inflammatory bowel disease: A prospective, observational cohort study
M. Barreiro-de Acosta, R. Ferreiro, M. Iglesias, A. Lorenzo, J.E. Dominguez-Muñoz, University Hospital Santiago de Compostela, Gastroenterology, Santiago, Spain
P. Zita1, T. Koller1, J. Toth1, M. Huorka1, Z. Zelinkova1, S. Oravcova1, T. Hlavaty1, 1University hospital Bratislava, Department of Gastroenterology and Hepatology, Bratislava, Slovakia
Evaluation of a service to manage Inflammatory Bowel Disease (IBD) in Pregnancy.
C. Parker*1, J. Waugh2, M. Gunn1
1Royal Victoria Infirmary, Gastroenterology, Newcastle upon Tyne, United Kingdom, 2Royal Victoria Infirmary, Obstetrics, Newcastle upon Tyne, United Kingdom
IBD in elderly Romanian patients: epidemiological and phenotypical characteristics
L. Gheorghe1, R. Iacob1, S. Iacob1, R. Vadan1, L. Guinea1, M. Greere1, B. Cotruta1, D. Dobru2, C. Mihai3, G. Stefanescu3, R. Zaharie4, M. Ilie5, M. Jinga6, M. Diculescu1, C. Gheorghe1, on behalf of the IBDPROSPECT Study Group, 1Fundeni Clinical Institute, Digestive Diseases and Liver Transplantation Center, Bucharest, Romania, 2Municipal Hospital Targu Mures, Gastroenterology, Targu Mures, Romania, 3Gastroenterology and Hepatology Institute Iasi, Gastroenterology, Iasi, Romania, 43rd Medical Clinic Cluj-Napoca, Gastroenterology, Cluj-Napoca, Romania, 5Floreasca Emergency Hospital, Gastroenterology, Bucharest, Romania, 6Central Military Hospital, Gastroenterology, Bucharest, Romania
M. Dranga1, C. Mihai1, E. Toader1, G. Dumitrescu1, I. Pintilie1, A.M. Blaj2, C. Cijevschi Prelipcean1, 1University of Medicine and Pharmacy Gr. T. Popa, Institute of Gastroenterology and Hepatology, Iasi, Romania, 2Institute of Gastroenterology and Hepatology, Iasi, Romania
Granulo-monocytes Apheresis Induce TGFbeta1 Modulation in Neutrophils of Patients Suffering from Ulcerative Colitis: A Possible Role of Soluble HLA-I Molecules.
M. Ghio1, G. Bodini*1, P. Contini1, V. Savarino1, E. Savarino1, 2
1IRCCS San Martino Genova, Dipartimento di medicina interna, Genova, Italy, 2University of Padua, Department of Surgery, Oncology and Gastroenterology, padova, Italy